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Abstract
Cellular zinc transport has not been fully characterized. The role of an anion carrier was investigated by treating normal
 .human fibroblasts, and those carrying a mutation which affects zinc transport, acrodermatitis enteropathica AE , with the
 y1 65 .anion carrier inhibitor, probenecid. Zinc uptake 2, 10, or 20 mmol l zinc was determined during initial rates of uptake
 . y115 min following treatment with 0, 10 or 20 mmol l probenecid. Probenecid stimulated extracellular zinc binding in
normal and AE fibroblasts. Probenecid inhibited the internalization of zinc in normal, but not AE, fibroblasts. Normal
fibroblasts exhibited an apparent K which was reduced by 53% and 44% in the 10 and 20 mmol ly1 probenecid treatedm
cells. The V was also reduced in the normal fibroblasts by 51% and 50% in the 10 and 20 mmol ly1 probenecid treatedmax
cells. The results suggest that a probenecid-sensitive anion carrier is involved in the internalization of zinc in human
fibroblasts. The lack of an effect of probenecid on the internalization of zinc in the AE fibroblasts suggests that the mutation
involves a probenecid-sensitive anion transport system, and that there may be a secondary mechanism for zinc transport in
these cells. q 1998 Elsevier Science B.V.
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1. Introduction
The cellular mechanism for zinc uptake has not
been fully characterized. One aspect of cellular zinc
uptake appears to involve an anion carrier system.
Zinc uptake into human erythrocytes is stimulated by
bicarbonate and chloride, and inhibited by the band 3
anion exchange inhibitor 4,4X-diiosthiocyanatostil-
X  . w xbene-2,2 -disulphonic acid DIDS 1,2 . The trans-
ported complex has been proposed to be
w  . xy w x y w  .Zn HCO Cl 1 , ZnCO Cl or Zn HCO ClP3 2 3 3
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xy w xOH 2 . Bicarbonate also stimulates zinc uptake
w xinto human fibroblasts 3 . Brush border membrane
vesicles from pig small intestine also appear to trans-
port zinc via an anion carrier system, although a
w xthiocyanate complex was the anionic species 4–6 .
However, this mechanism was not DIDS sensitive
w x6 .
Anion transport mechanisms other than those sen-
sitive to DIDS have been identified. These include
w x wa-cyano-4-hydroxycinnamate 7 and r- dipropylsul-
x  . w xfamoyl benzoic acid probenecid 8–10 . The mech-
anism of inhibition of these inhibitors on cellular zinc
transport has not been investigated. Probenecid in-
hibits cellular folate and methotrexate transport by
w xL1210 and MA104 cells 9,10 . Furthermore, a
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probenecid-sensitive anion transport mechanism has
been proposed in the model for non-clathrin coated
w xpit vesicular transport, termed potocytosis 11,12 .
We have previously reported that nystatin, a sterol-bi-
nding antibiotic that inhibits the formation of caveo-
 .lae the vesicles of potocytosis , also inhibits zinc
w xtransport 13 . If zinc transport occurs via potocyto-
sis, it may also be inhibited by probenecid. Thus, we
hypothesized that zinc transport would be inhibited
by probenecid. Further, we also hypothesized that
probenecid would inhibit further the poor zinc uptake
by fibroblasts containing the acrodermatitis entero-
pathica mutation. We used these cells because we
hypothesized that more than one mechanism might
exist for zinc transport. Our results support these
hypotheses. We found that cellular zinc transport
occurs through a probenecid-sensitive anion carrier,
suggesting that potocytosis is involved. However, the
results also suggest the existence of a secondary zinc
uptake system. The AE mutation significantly inhib-
ited zinc uptake but probenecid treatment did not
further reduce zinc transport in these cells.
2. Materials and methods
2.1. Cell culture
Fibroblasts were purchased from the Coriell Insti-
tute for Medical Research Genetic Mutant Cell
 .Repository Camden, NJ . Fibroblasts were from
 .Caucasian males. The normal fibroblasts GM5659B
were obtained from a 14 month old infant. Acroder-
 .matitis enteropathica GM2814 fibroblasts were from
a 6 month old infant. The cells were grown in
 . minimal essential medium Eagle’s GIBCO–BRL,
. y1Grand Island, NY containing 0.01 mg l gentam-
icin, 0.06 g ly1 penicillin, 0.1 g ly1 streptomycin,
20% uninactivated fetal calf serum and double the
normal concentrations of essential and non-essential
amino acids and vitamins. The growth medium con-
tained approximately 16 mmol ly1 zinc as measured
by atomic absorption spectroscopy.
2.2. Zinc transport
The fibroblasts were subcultured in 3.83 cm2 dishes
 . 4 y222 mm diameter at 1.3=10 cells cm and grown
for 4 days. On the fourth day, the growth medium
was removed and the cells rinsed twice with HGS
 y1 y1buffer 10 mmol l HEPES, 138.3 mmol l NaCl,
7 mmol ly1 KCl, 5.6 mmol ly1 dextrose, 1.3 mmol
y1 .l CaCl , pH 7.4 at 378C. The cells were then2
incubated at 378C for 20 min with HGS buffer or
buffer containing 10 or 20 mmol ly1 probenecid, pH
7.5. These concentrations of probenecid were chosen
because 10 mmol ly1 has been shown to inhibit
w xfolate transport in MA104 cells 10 . The effect on
zinc transport of 20 mmol ly1 probenecid was inves-
tigated to determine whether maximal inhibition of
zinc transport was obtained at 10 mmol ly1
probenecid.
The incubation buffer was removed and the cells
were incubated for 15 min with fresh buffers at 378C
y1 65  .containing 2 to 20 mmol l zinc 1 kBq . Previous
results indicated that zinc uptake in these fibroblasts
w xwas linear between 10 and 30 min 22 , indicating
that the 15 min time point is within the initial rate for
zinc uptake. Carrier-free 65zinc was used as a tracer
 .Amersham, Arlington Heights, IL . Transport was
stopped by placing the culture dishes on ice. The
labeled buffer was removed and the fibroblasts were
 y1rinsed with 1 ml ice-cold EDTA buffer 10 mmol l
HEPES, 150 mmol ly1 NaCl, 10 mmol ly1 EDTA,
.pH 7.4 for 30 s. The reaction was stopped with the
addition of 1 ml ice-cold HGS buffer. The buffers
were removed and the cells rinsed with 1 ml ice-cold
HGS. This buffer was removed and the cells were
rinsed for 30 s with ice-cold acidic saline 150 mmol
y1 y1 .l NaCl, 40 mmol l acetic acid, pH 3.0 . The
reaction was stopped by the addition of 1 ml ice-cold
HGS. This rinse was removed and placed in scintilla-
tion vials. The HGS rinse was repeated and also
placed with the acidic saline rinse, and the radioactiv-
ity of the solution determined by gamma counting.
Preliminary experiments indicated that a single EDTA
rinse removed 15.2% of the cell-associated label,
compared to 17.6% of the cell-associated label after 4
EDTA rinses. A single acidic saline rinse removed
17.2% of the label compared to 19.29% of the label
removed after four acidic saline rinses. However, a
single rinse with EDTA followed by a single rinse
with acidic saline removed 19.8% of the cell-associ-
ated zinc. Therefore, this method was chosen for
determining externally bound and internalized zinc.
The cells were lysed by adding 0.2 M NaOH–0.2%
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sodium dodecyl sulfate for 15 min at room tempera-
ture and freezing overnight at y208C. The lysate was
thawed and the radioactivity determined by gamma
counting. An aliquot was used for protein determina-
w xtion with the bicinchoninic acid method 21 . The
amount of zinc present in the acidic saline rinse
represents externally-bound, acid-sensitive cellular
zinc. The amount of zinc present in the NaOH–SDS
solution represents internalized, acid-resistant zinc.
2.3. Data analysis and statistics
The data were analyzed by the Lineweaver–Burke
double reciprocal plot. The intercepts of the x-axis or
y-axis were used to determine the apparent K andm
V , respectively. Significance was determined bymax
ANOVA and Student–Neuman–Keuls unpaired t-test
 e .Statmost 1.01, DataMost, Salt Lake City, UT .
Differences were considered significant when p-
0.05.
3. Results
The accumulation of zinc by human fibroblasts, its
binding to external binding sites, and its transport
into human fibroblasts appeared to begin to saturate
y1  .at 20 mmol l zinc Figs. 1 and 2 . The exception
was Fig. 2C, in which zinc transport in the AE
fibroblasts appeared linear at the zinc concentrations
used. The total cell-associated zinc Fig. 1A and Fig.
.2A was divided into an acid-sensitive, externally
 .bound zinc compartment Fig. 1B and Fig. 2B and
an acid-resistant, internalized zinc compartment Fig.
.1C and Fig. 2C .
Treatment of normal fibroblasts with 10 or 20
mmol ly1 probenecid did not affect the total cell-as-
 .sociated zinc Fig. 1A . Probenecid at a concentration
of 10 mmol ly1 significantly increased the accumula-
tion of zinc in the external compartment at 2 mmol
y1  .l zinc Fig. 1B by 25% over normal levels, but not
at any other zinc concentration. Probenecid at a
concentration of 20 mmol ly1 significantly increased
the accumulation of zinc in the external compartment
at 2 mmol ly1 zinc by 44%, and at 5 to 20 mmol ly1
 .zinc by 29% to 33%, over normal levels Fig. 1B .
Increasing the probenecid concentration from 10 to
20 mmol ly1 significantly increased the accumulation
Fig. 1. The effect of probenecid on zinc transport in normal
human fibroblasts. Zinc transport was measured in normal fibrob-
lasts treated with 10 or 20 mmol ly1 probenecid. Each data point
 .represents the mean"SE ns9 . Statistical analysis was per-
formed by the Student’s t-test. The data points which are signifi-
 .cantly different from each other P -0.05 are indicated by a, b,
 y1or c a: control vs. 10 mmol l probenecid; b: control vs. 20
mmol ly1 probenecid; c: 10 mmol ly1 probenecid vs. 20 mmol
y1 .l probenecid . The concentrations of probenecid are designated
 y1 .  y1P10 10 mmol l probenecid and P20 20 mmol l
.  . 65probenecid . A Total cell-associated zinc. These data include
 .zinc in the acid-sensitive and the acid-resistant compartments. B
65  .Externally bound, acid-sensitive zinc. C Internalized, acid-re-
sistant 65zinc.
of zinc in the external compartment of these cells at 5
and 10 mmol ly1 zinc by 33% and 20%, respectively.
AE fibroblasts treated with probenecid exhibited
significant increases in total cell-associated zinc at all
 .zinc concentrations Fig. 2A . Zinc accumulation in
the external compartment was significant from 2 to
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20 mmol ly1 zinc regardless of the probenecid con-
centration, and exhibited an increase of 58% to 88%
above control levels. The accumulation of zinc in the
external compartment was not significantly increased
further by increasing the probenecid concentration
from 10 to 20 mmol ly1.
Fig. 2. The effect of probenecid on zinc transport in acrodermati-
 .tis enteropathica AE fibroblasts. Zinc transport was measured
in AE fibroblasts treated with 10 or 20 mmol ly1 probenecid.
 .Each data point represents the mean"SE ns9 . Statistical
analysis was performed by the Student’s t-test. The data points
 .which are significantly different from each other P -0.05 are
 y1indicated by a and b a: control vs. 10 mmol l probenecid; b:
y1 .control vs. 20 mmol l probenecid . The concentrations of
 y1 .probenecid are designated P10 10 mmol l probenecid and
 y1 .P20 20 mmol l probenecid . The control AE data points
which are significantly different from the control normal data
).  .points are indicated by an asterisk . A Total cell-associated
65
zinc. These data include zinc in the acid-sensitive and the
 .acid-resistant compartments. B Externally bound, acid-sensitive
65  . 65zinc. C Internalized, acid-resistant zinc.
Table 1
Apparent K and V values of normal fibroblasts treated withm max
probenecid
0 mM 10 mM 20 mM
a a,b a,cK 5.19"0.87 2.44"0.46 2.93"0.91m
a a,b a,cV 32.36"5.23 15.83"1.56 16.05"1.79max
The data are expressed as the mean"SE. The K and V werem max
determined by fitting the curves generated from the data using
the Lineweaver–Burke double reciprocal plot. The mean values
for the data points in Fig. 1C were also analyzed by a direct
linear plot, which indicated decreases in K and V withm max
probenecid treatment as well. Statistical analysis was performed
on the K and V values by ANOVA using the Student–Neu-m max
man–Keuls method. The units for the apparent K are mM. Them
units for the V are pmolrminrmg protein. For each kineticmax
parameter, values with the same superscripts are significantly
 .different from each other P -0.05 .
The internalization of zinc in normal fibroblasts
 .Fig. 1C was significantly reduced in the 10 mmol
ly1 probenecid treated cells at zinc concentrations of
5 and 20 mmol ly1 by 34% and 32%, respectively.
Normal cells treated with 20 mmol ly1 probenecid
exhibited reduced zinc accumulation in their internal
compartment at zinc concentrations from 5 to 20
yl  .mmol by 32% to 49%, respectively when com-
pared to untreated control cells. Probenecid treatment
of the AE fibroblasts did not affect the accumulation
 .of zinc in their internal compartment Fig. 2C . Zinc
transport was affected by the AE mutation alone cf.
w xthe results for the control data of Fig. 2 AE cells
w x.with Fig. 1 normal cells .
The apparent K and the V were determinedm max
 .from the data in Fig. 1C Table 1 . Normal fibrob-
lasts exhibited a significant reduction in both kinetic
parameters in the presence of probenecid. Probenecid
treatment at 10 and 20 mmol ly1 reduced the appar-
ent K by 53% and 44% compared to control,m
respectively. Probenecid treatment at 10 and 20 mmol
ly1 also reduced the V by 51% and 50% com-max
pared to control, respectively.
4. Discussion
The hypothesis tested by the present work was that
probenecid would inhibit zinc transport in normal and
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AE fibroblasts. The results from normal fibroblasts
support the hypothesis, and are consistent with cellu-
lar zinc transport involving an anion carrier system.
Probenecid has been used to identify the role of anion
w xtransport in the cellular uptake of folate 10 and
w xmethotrexate 9,14–16 , and may be associated with
the vesicular transport mechanism called potocytosis
w x11 .
However, probenecid treatment did not inhibit zinc
transport in the AE fibroblasts any further than was
accounted for by the mutation alone. The results from
these cells suggest that the probenecid-sensitive anion
transport system may be the defect caused by the AE
mutation. These results suggest that a secondary zinc
transport system is available in the AE cells. Though
not compensatory, this system is apparently capable
of transporting sufficient zinc for relatively normal
cellular function. However, the AE fibroblasts do
contain less intracellular zinc and exhibit a reduction
in the activity of the zinc-dependent enzyme, 5X-
nucleotidase, when compared with normal fibroblasts
w x22 .
The V and the apparent K measured in themax m
normal cells were affected by probenecid treatment to
the same degree, indicating that uncompetitive inhibi-
w xtion was occurring 17 . Probenecid apparently blocks
the anion carrier, thereby restricting the transport of
zinc into the cell. The reduced transport appears to
increase the availability of extracellular zinc-binding
sites, as indicated by an increase in the presence of
zinc in the acid-sensitive compartment in the
probenecid-treated cells. It is not known whether
probenecid forms a complex with zinc, thereby af-
fecting its binding to the cell surface. However, if
this were so one might expect similar reductions in
the internalization of zinc with probenecid treatment
regardless of the genotype of the cell. The results in
Fig. 1C and Fig. 2C indicate that probenecid only
inhibited zinc internalization in the normal fibrob-
lasts, not in the AE fibroblasts.
The model of potocytosis for the transmembrane
transport of folate, and for zinc, involves the forma-
tion of vesicles through a cholesterol-dependent pro-
cess, the activation of a monensin-sensitive proton
pump, and transport through a probenecid-sensitive
w xanion carrier 11 . Previous results from this lab
indicate that cellular zinc transport in fibroblasts is
w xinhibited by nystatin 13 , a membrane sterol-binding
drug which also inhibits the formation of the potocy-
w xtotic vesicles called caveolae 18 . Furthermore, the
depletion of cellular cholesterol, i.e., the reduction in
the number of functional caveolae, significantly re-
duces the cellular accumulation of folate and affects
w xthe internalization of the folate receptor 19,20 . The
depletion of cellular cholesterol also reduces the cel-
 .lular uptake of zinc Grider, unpublished data .
Therefore, the data support the hypothesis that poto-
cytosis may be involved in the transmembrane trans-
port of zinc.
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